Rifampicin (Rifampin, Rifadin)

C. diff Risk

NA

Oral Bioavailability

NA

Approximate Cost

Dosing

No dosage adjustment necessary. Administer after hemodialysis on dialysis days.

General Information

Common Usage

  • Mycobacterial infections

  • Brucellosis

  • Osteomyelitis

  • Prosthetic joint infections due to Staphylococcus aureus

Always use in combination with other agents

Drug Monitoring

Lab

  • Baseline and periodic LFTs

Clinical

  • Multiple drug interactions

Adverse Effects

  • Nausea/vomiting, diarrhea

  • Abnormal liver enzymes

  • Rash (Steven-Johnson syndrome)

  • Myopathy

Major Interactions

Inducer of many CYP enzymes including 3A4, and 2C9. Review patients medications carefully.

Additional Information

  • Should never be used as monotherapy

  • May discolor bodily secretions (yellow-reddish). Caution in contact lens wearers.

Pharmacology

Antimicrobial class: Antimycobacterial

Pregnancy category: C

Average serum half life: 3-4 hr

Biliary penetration: Therapeutic

CSF penetration: Therapeutic

Lung penetration: Therapeutic

Route of Elimination: Feces